PEARRL
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences
  • PEARRL Project
    • Beneficiaries
    • Partner Organisation
    • People >
      • Supervisors >
        • Prof. B. Griffin
        • Prof. M. Kuentz
        • Dr. C. Saal
        • Dr. L. Kalantzi
        • Dr. E. Kostewicz
        • Prof. C. Reppas
        • Prof. J. Dressman
        • Dr. N. Fotaki
        • Dr. R. Holm
        • Dr. M. Vertzoni
        • Dr. K. Box
        • Prof. C. O'Driscoll
      • Researchers >
        • Niklas Köhl (ESR1)
        • Felix Ditzinger (ESR 2)
        • Daniel Price (ESR 3)
        • Georgia Tsakiridou (ESR 4)
        • Sandra Jankovic (ESR 5)
        • Chara Litou (ESR 6)
        • Christina Pentafragka (ESR 7)
        • Rafael Leal Monteiro Paraiso (ESR 8)
        • Laura Henze (ESR 9)
        • Patrick O'Dwyer (ESR 10)
        • Marina Statelova (ESR 11)
        • Mariana Guimarães (ESR 12)
        • Ioannis Loisios-Konstantinidis (ESR 13)
        • Alexandra-Roxana Ilie (ESR 14)
        • Angela Effinger (ESR 15)
      • Scientific Advisory Board >
        • Prof. Carla Caramella
        • Dr. Paul Dickinson
        • Dr. Andrea Edginton
        • Dr. Susanne Keitel
        • Dr. Mehul Mehta
    • PEARRL Wiki >
      • FAQ
      • Glossary
  • Research
    • Workplan
    • WP1: Bio-enabling formulations
    • WP2: Biopharmaceutical tools
    • WP3: In silico methods
    • Results >
      • Scientific Publications
      • Conference Contributions
      • InfoPEARRLs
      • Media
  • Training
    • Local
    • Network-wide
    • PEARRL Online Learning Portal
    • Member Area
  • News
  • Events & Meetings
    • Webinar: Regulatory Science Apprentice
    • Annual Meeting 2019
    • Model Informed Drug Development Symposium 2019
    • Annual Meeting 2018
    • Regulatory Science Symposium 2018
    • Annual Meeting 2017
    • Regulatory Science Symposium 2017
    • PEARRL Calendar
    • International Conferences

Researchers

Academic excellence, industry experience and regulatory involvement are essential to bridge the training gap that currently exists between training drug development scientists expertise in formulation science as well as a thorough understanding of regulatory science. PEARRL will provide a comprehensive, interdisciplinary and multi-sectorial training programme that will imbue ESRs with a wide range of technological and transferable skills to ensure their high employability.
Picture

ESR 1: Niklas Köhl

Lipid based formulations (LBF) as bio-enabling formulation technology
Institute: University College Cork, School of Pharmacy

Picture

ESR 2: Felix Ditzinger

Supersaturating oral delivery systems of poorly water-soluble compounds produced by hot melt extrusion
Institute: University of Applied Sciences & Arts Northwestern Switzerland, Institute of Pharma Technology

Picture

ESR 3: Daniel Price

Development of novel mesoporous silica-based formulations
Institute: Merck Group, Molecule Characterisation

Picture

ESR 4: Georgia Tsakiridou

Amorphous Solid Dispersion (ASDs) formulations for per os administered bio-enabling drug products
Institute: Pharmathen SA, Product Design & Evaluation

Picture

ESR 5: Sandra Jankovic

Novels in vitro tools and modeling to support solid dispersion formulation development
Institute: University of Applied Sciences & Arts Northwestern Switzerland, Institute of Pharma Technology

Picture

ESR 6: Chara Litou

Transfer model utility – investigation of gastro-intestinal (GI) supersaturation and precipitation from discovery to regulatory submission
Institute: Johann Wolfgang Goethe University, Institute of Pharmaceutical Technology

Picture

ESR 7: Christina Pentafragka

Developing in vitro tools to forecast gastrointestinal drug transfer in the fed state
Institute: National and Kapodistrian University of Athens, Faculty of Pharmacy


Picture

ESR 8: Rafael Leal Monteiro Paraiso

A new approach to setting bioequivalence limits using Physiologically based Pharmacokinetic (PBPK) modelling
Institute: Johann Wolfgang Goethe University, Institute of Pharmaceutical Technology

Picture

ESR 9: Laura Henze

Exploring the utility of the porcine model for predicting bio-enabling oral drug products performance in humans
Institute: University College Cork, School of Pharmacy

Picture

ESR 10: Patrick O'Dwyer

Small-scale dissolution assays for evaluating API and formulation behaviour
Institute:
Pion Inc. (UK) Ltd.

Picture

ESR 11: Marina Statelova

Developing new in vitro and in vivo methods to predict performance of paediatric formulations
Institute: National and Kapodistrian University of Athens, Faculty of Pharmacy


Picture

ESR 12: Mariana Guimarães

Developing in vitro and in silico approaches to predict clinical outcomes with a special focus on paediatrics
Institute: University of Bath, School of Pharmacy


Picture

ESR 13: Ioannis Loisios-Konstantinidis

Extension of biowaivers to BCS class II compound using biorelevant dissolution testing
Institute: Johann Wolfgang Goethe University, Institute of Pharmaceutical Technology


Picture

ESR 14: Alexandra-Roxana Ilie

Developing in vitro and in silico models to predict in vivo performance of supersaturated Self-nano-emulsifying drug delivery systems
Institute: Janssen Pharmaceutical N.V., Faculty of Health and Medical Sciences

Picture

ESR 15: Angela Effinger

Developing in vitro and in silico approaches to predict the impact of gastrointestinal disease states on drug product performance
Institute: University of Bath, School of Pharmacy

Picture
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under grant agreement No 674909.
Disclaimer | Member Area
© accelopment Schweiz AG 2019. ALL RIGHTS RESERVED.